AI Article Synopsis

  • Knee osteoarthritis (OA) is a slow progression of cartilage damage leading to pain and difficulties in movement, with standard pain medications not effective for everyone.
  • A systematic review analyzed 10 studies from 2016-2023 on the use of platelet-rich plasma (PRP) injections for reducing OA pain compared to a placebo.
  • While some studies showed significant improvement in symptoms for PRP-treated patients, results were inconsistent, indicating the need for more research to clarify PRP's effectiveness and consider other factors like follow-up times and patient conditions.

Article Abstract

Purpose Of Review: Knee osteoarthritis (OA) is a gradual deterioration of articular cartilage characterized by pain and physical dysfunction. Although analgesic pharmacological agents are the first-line treatment for knee OA, they are not effective for all patients. In this study, we evaluate the efficacy of an intra-articular injection treatment using platelet-rich plasma (PRP) in reducing pain and improving functional ability.

Recent Findings: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, this systematic review and meta-analysis (SR/MA) provides an updated overview for the role of PRP in knee OA treatment. Ten articles, published between 2016 and 2023, met the inclusion criteria and compared PRP treatment to a placebo control at six-month follow-up. A total of 9,409 potential studies were identified from a review of four different databases: PubMed (n = 4595), Cochrane (n = 4252), VHL (n = 112), and OpenSigle (n = 450). After the titles and abstracts and inclusion and exclusion criteria were considered, a total of 10 studies were analyzed. Although a significant improvement among PRP-treated groups in some studies was found, there was variability such as where the aforementioned scores appeared to worsen and some only demonstrated trends. Overall, PRP may be a promising treatment for symptomatic knee OA. However, further research is necessary to determine the efficacy of PRP in treating knee OA, with specific considerations for times at follow-up, frequency and dosage of injections, and comorbidities, which were unaccounted for in this SR/MA.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11916-024-01320-9DOI Listing

Publication Analysis

Top Keywords

efficacy intra-articular
8
platelet-rich plasma
8
treatment knee
8
knee osteoarthritis
8
systematic review
8
review meta-analysis
8
treatment
6
knee
6
prp
5
intra-articular platelet-rich
4

Similar Publications

Background: Meniscal injuries that fail to heal instigate catabolic changes in the knee's microenvironment, posing a high risk for developing posttraumatic osteoarthritis (PTOA). Previous research has suggested that human cartilage-derived progenitor cells (hCPCs) can stimulate meniscal repair in a manner that depends on stromal cell-derived factor 1 (SDF-1) pathway activity.

Hypothesis: Overexpressing the SDF-1 receptor CXCR4 in hCPCs will increase cell trafficking and further improve the repair efficacy of meniscal injuries.

View Article and Find Full Text PDF
Article Synopsis
  • Knee osteoarthritis (OA) is a slow progression of cartilage damage leading to pain and difficulties in movement, with standard pain medications not effective for everyone.
  • A systematic review analyzed 10 studies from 2016-2023 on the use of platelet-rich plasma (PRP) injections for reducing OA pain compared to a placebo.
  • While some studies showed significant improvement in symptoms for PRP-treated patients, results were inconsistent, indicating the need for more research to clarify PRP's effectiveness and consider other factors like follow-up times and patient conditions.
View Article and Find Full Text PDF

Persistent anterolateral ankle pain is a debilitating condition often associated with soft tissue impingement following inversion injuries. It can lead to significant limitations in daily activities and overall quality of life, particularly in individuals with chronic ankle instability. This systematic review examines the efficacy and safety of minimally invasive arthroscopic decompression techniques in managing anterolateral ankle impingement syndrome.

View Article and Find Full Text PDF

Osteoarthritis, particularly temporomandibular joint (TMJ) osteoarthritis (OA), poses significant challenges in diagnosis and treatment. Recent studies suggest that nanomaterials hold considerable promise in treating TMJ-OA, showing validated efficacy in animal models. However, further research is required to ensure their long-term safety within the TMJ-OA environment.

View Article and Find Full Text PDF

Introduction: Lorecivivint (LOR), a CDC-like kinase/dual-specificity tyrosine kinase (CLK/DYRK) inhibitor thought to modulate inflammatory and Wnt pathways, is being developed as a potential intra-articular knee osteoarthritis (OA) treatment. The objective of this trial was to evaluate long-term safety of LOR within an observational extension of two phase 2 trials.

Methods: This 60-month, observational extension study (NCT02951026) of a 12-month phase 2a trial (NCT02536833) and 6-month phase 2b trial (NCT03122860) was administratively closed after 36 months as data inferences became limited.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!